The immunoblot with anti-CCDC6 antibody indicated that the CCDC6 half-life was reduced upon P5091 pretreatment in bladder cancer cells (Fig. 1c, d, e, f). The gene discussed is CCDC6; the disease is urinary bladder carcinoma.